2024
DOI: 10.1002/pd.6572
|View full text |Cite
|
Sign up to set email alerts
|

Interdependence of placenta and fetal cardiac development

Rachel L. Leon,
Lynn Bitar,
Vidya Rajagopalan
et al.

Abstract: The placenta and fetal heart undergo development concurrently during early pregnancy, and, while human studies have reported associations between placental abnormalities and congenital heart disease (CHD), the nature of this relationship remains incompletely understood. Evidence from animal studies suggests a plausible cause and effect connection between placental abnormalities and fetal CHD. Biomechanical models demonstrate the influence of mechanical forces on cardiac development, whereas genetic models high… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 123 publications
0
0
0
Order By: Relevance
“…In the latter half of gestation, the relationship between FCHD and abnormal placentation is reviewed by Leon et al Their group highlights the animal, genetic and mechanical studies that support the clinical associations of increased preeclampsia and growth restriction in pregnancies complicated by FCHD. 18 As FGR and preterm birth increase morbidity and mortality among FCHD, risk reduction measures for these conditions, such as low dose aspirin, now routine for those at risk of preeclampsia, warrant further exploration. These associations remind us of the complex interplay between the pregnant person and FCHD and, as discussed above, the need to pay attention to both.…”
mentioning
confidence: 99%
“…In the latter half of gestation, the relationship between FCHD and abnormal placentation is reviewed by Leon et al Their group highlights the animal, genetic and mechanical studies that support the clinical associations of increased preeclampsia and growth restriction in pregnancies complicated by FCHD. 18 As FGR and preterm birth increase morbidity and mortality among FCHD, risk reduction measures for these conditions, such as low dose aspirin, now routine for those at risk of preeclampsia, warrant further exploration. These associations remind us of the complex interplay between the pregnant person and FCHD and, as discussed above, the need to pay attention to both.…”
mentioning
confidence: 99%